Tirzepatide escalation began at 2.5mg/week for 4 weeks, escalating by 2.5mg increments every 4 weeks to the target dose
But the clinical pattern is real: patients with MCAS, POTS, dysautonomia, multiple chemical sensitivity, and related conditions who exist in a state of chronic, low-level immune activation that conventional medicine struggles to categorize and largely fails to treat
Appetite control Improved metabolism Heart health benefits Supports long-term health Benefits of Weight Loss Treatment Overview The Benefits of a Medical Weight-Loss Program Starting a new weight-loss program can be intimidating
The behavior change is easier
Lab work: Periodic blood tests to monitor your response and safety
Some patients who consistently eat smaller meals over extended periods may experience what could be described as stomach adaptation